Better Weight Loss Means Protecting More Than Fat Loss Alone Why fast results can come with a quieter tradeoff when lean mass drops alongside body fat How muscle-preserving strategies may matter most for…
Promising Research Still Needs Clinical Distance Why obesity-linked cancer biology has pushed metabolic therapies into a more serious scientific conversation What tumor-slowing signals in early studies can suggest, and what they still cannot…
A Label Change Does Not Replace Individual Risk Review Why the 2025 FDA shift changes the conversation around menopausal hormone therapy without removing the need for careful screening How timing, formulation, and route…
When menopause symptoms return after cancer treatment, the path forward needs nuance Older hormone studies still shape today’s caution, even as newer expert consensus pushes for more individualized risk review. Non-hormonal care and…
Weight-loss care is expanding well beyond the incretin pathway FGF21 and GDF15 analogs are drawing attention because they target metabolism, appetite signaling, and liver fat through different biologic routes. This matters most for…
When fat loss stops being just an appetite story Why brown fat and thermogenesis matter when calorie burn feels unusually stubborn. How metabolism-focused strategies differ from older, appetite-only weight loss approaches. Which next…
When Hormone Dosing Needs a Closer Look Helpful context for readers dealing with hot flashes, sleep disruption, mood variability, or dose-sensitive symptom swings. A clearer bridge between today’s lab-based hormone care and the…
Why this research matters before symptoms fully take over Useful context for women watching cycle changes, sleep disruption, metabolic shifts, or other signs that perimenopause may be changing the pace of daily life.…
Where brain-based weight maintenance may fit Useful for readers looking at appetite rebound, post-GLP-1 maintenance, or weight regain after early success. Clarifies how CNS-directed therapies differ from gut-based medications and why tolerability can…
The future may be physiologic, but today’s hormone decisions still matter Bioengineered ovaries are an emerging research path, not a current treatment option. The core reader question usually comes down to whether current…